At what systolic blood pressure (SBP) and diastolic blood pressure (DBP) thresholds should atenolol be held?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Pressure Hold Parameters for Atenolol

Based on FDA labeling and clinical trial exclusion criteria, atenolol should be held when systolic blood pressure is less than 100 mmHg. There is no specific diastolic blood pressure threshold established in the FDA labeling for holding atenolol 1.

Specific Hold Parameters

Systolic Blood Pressure Threshold

  • Hold atenolol if SBP <100 mmHg 1
  • This threshold comes directly from the ISIS-1 trial, which excluded patients with systolic blood pressure consistently below 100 mmHg from receiving atenolol in the acute myocardial infarction setting
  • The FDA label explicitly states: "Patients with a heart rate of < 50 bpm or systolic blood pressure < 100 mm Hg, or with other contraindications to beta blockade were excluded" 1

Heart Rate Threshold (Additional Critical Parameter)

  • Hold atenolol if heart rate <50 bpm 1
  • This is equally important as the blood pressure parameter and comes from the same FDA labeling

Diastolic Blood Pressure

  • No specific DBP hold parameter is established in FDA labeling 1
  • The clinical trials and drug labeling focus on systolic pressure and heart rate as the primary safety thresholds
  • General clinical practice suggests caution with DBP <60 mmHg, but this is not codified in the official labeling

Clinical Context and Rationale

The 100 mmHg systolic threshold reflects the physiologic principle that beta-blockers can impair the heart's ability to respond to sympathetic stimulation 1. Patients who depend on sympathetic drive to maintain adequate cardiac output and blood pressure are poor candidates for beta-blockade 1.

Important Caveats

  • The ISIS-1 trial data suggest that patients with borderline blood pressure (less than 120 mmHg systolic), especially if over 60 years of age, are less likely to benefit from atenolol 1
  • In elderly patients with systolic BP <120 mmHg, exercise particular caution even if above the 100 mmHg hold threshold

Additional Monitoring Considerations

  • Watch for signs of hypotension, marked bradycardia, vertigo, syncope, or postural hypotension 1
  • These symptoms may occur even with BP above the hold threshold, particularly when atenolol is combined with other agents that lower blood pressure or heart rate
  • Cardiac failure not controlled by 80 mg IV furosemide is an absolute contraindication to atenolol in the acute MI setting 1

Related Questions

Should the dosage of enalapril (ACE inhibitor) be increased from 10mg daily to twice a day for a patient with persistent hypertension?
What is the recommended dose of Atenolol (beta blocker) for adults with hypertension?
What is the recommended protocol for weaning a patient off atenolol (beta blocker)?
At what systolic and diastolic blood pressure thresholds does stroke risk become markedly increased?
What is the recommended treatment and follow‑up for a 57‑year‑old African‑American male on lisinopril 10 mg daily and metformin 500 mg twice daily who presents for routine follow‑up with uncontrolled stage 2 hypertension (blood pressure 156/102 mm Hg), oxygen saturation 93 % on room air, and hemoglobin A1c 6.3 %?
Why does vomiting occur with post‑nasal secretions, especially when brushing teeth, and how can it be prevented?
What is the dextrose content in a 3-in-1 parenteral nutrition (PN) admixture?
If a proton pump inhibitor (PPI) cannot be used, what alternative medications or non‑pharmacologic measures can be employed to reduce nasal/post‑nasal secretions?
What is the appropriate management of recurrent oral ulcers in a child that appear after a common cold?
What is the recommended ceftriaxone dose for an otherwise healthy adult with community‑acquired pneumonia and normal renal function, and how should the dose be adjusted in renal impairment?
What is the recommended ceftriaxone dose for an adult with community‑acquired pneumonia and normal renal function, and how should it be adjusted for severe disease or risk factors for resistant organisms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.